Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sennosides vs PEG for Opioid-induced Constipation in Cancer
NCT01189409Phase 4Terminated
- Sponsor
- BC Cancer
- Start
- Jun 2010
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sennosides, macrogol in opioid-induced constipation (OIC), sponsored by BC Cancer. Started Jun 2010; status: terminated.
02
Drugs
sennosidesmacrogol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01189409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01189409.